|
MON1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64157576421076E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.40329978140608E-11 |
| Normal-vs-Stage2 |
6.23479999999343E-05 |
| Normal-vs-Stage3 |
1.56541446472147E-14 |
| Normal-vs-Stage4 |
6.7577055062884E-11 |
| Stage1-vs-Stage2 |
3.856600E-01 |
| Stage1-vs-Stage3 |
1.469990E-02 |
| Stage1-vs-Stage4 |
5.356000E-02 |
| Stage2-vs-Stage3 |
3.286300E-02 |
| Stage2-vs-Stage4 |
5.121800E-02 |
| Stage3-vs-Stage4 |
9.507600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.21902488103842E-13 |
| Normal-vs-AfricanAmerican |
2.82299999998514E-06 |
| Normal-vs-Asian |
4.05830002936369E-09 |
| Caucasian-vs-AfricanAmerican |
8.815600E-01 |
| Caucasian-vs-Asian |
8.054200E-01 |
| AfricanAmerican-vs-Asian |
9.716400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32560629140244E-12 |
| Normal-vs-Female |
2.2101209751213E-12 |
| Male-vs-Female |
3.276600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.87380008678895E-10 |
| Normal-vs-Age(41-60Yrs) |
5.40067990328907E-12 |
| Normal-vs-Age(61-80Yrs) |
4.77295980516601E-12 |
| Normal-vs-Age(81-100Yrs) |
6.478800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.173600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.475000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.811600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.794000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.699800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.543200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.477880E-03 |
| Classical-VS-Follicular |
7.054400E-01 |
| Classical-VS-Other |
7.695900E-02 |
| Classical-VS-Normal |
1.78135284301106E-12 |
| Tall-VS-Follicular |
6.361400E-03 |
| Tall-VS-Other |
5.412000E-01 |
| Tall-VS-Normal |
1.99018579394306E-12 |
| Follicular-VS-Other |
1.464390E-01 |
| Follicular-VS-Normal |
6.78939999998462E-07 |
| Other-VS-Normal |
6.49019999999778E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.13149950414982E-10 |
| Normal-vs-N1 |
8.45910008706596E-11 |
| N0-vs-N1 |
8.126100E-02 |
|
|
